1. Home
  2. ATRA vs ALTS Comparison

ATRA vs ALTS Comparison

Compare ATRA & ALTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATRA
  • ALTS
  • Stock Information
  • Founded
  • ATRA 2012
  • ALTS 1976
  • Country
  • ATRA United States
  • ALTS United States
  • Employees
  • ATRA N/A
  • ALTS N/A
  • Industry
  • ATRA Biotechnology: Biological Products (No Diagnostic Substances)
  • ALTS
  • Sector
  • ATRA Health Care
  • ALTS
  • Exchange
  • ATRA Nasdaq
  • ALTS NYSE
  • Market Cap
  • ATRA 65.1M
  • ALTS 54.0M
  • IPO Year
  • ATRA 2014
  • ALTS N/A
  • Fundamental
  • Price
  • ATRA $11.40
  • ALTS $3.84
  • Analyst Decision
  • ATRA Buy
  • ALTS
  • Analyst Count
  • ATRA 6
  • ALTS 0
  • Target Price
  • ATRA $26.50
  • ALTS N/A
  • AVG Volume (30 Days)
  • ATRA 77.5K
  • ALTS 209.2K
  • Earning Date
  • ATRA 11-12-2024
  • ALTS 01-03-2025
  • Dividend Yield
  • ATRA N/A
  • ALTS N/A
  • EPS Growth
  • ATRA N/A
  • ALTS N/A
  • EPS
  • ATRA N/A
  • ALTS N/A
  • Revenue
  • ATRA $100,439,000.00
  • ALTS $7,110,000.00
  • Revenue This Year
  • ATRA $1,346.63
  • ALTS N/A
  • Revenue Next Year
  • ATRA N/A
  • ALTS N/A
  • P/E Ratio
  • ATRA N/A
  • ALTS N/A
  • Revenue Growth
  • ATRA 2111.34
  • ALTS N/A
  • 52 Week Low
  • ATRA $6.50
  • ALTS $0.50
  • 52 Week High
  • ATRA $39.50
  • ALTS $5.26
  • Technical
  • Relative Strength Index (RSI)
  • ATRA 51.71
  • ALTS 68.94
  • Support Level
  • ATRA $9.13
  • ALTS $3.33
  • Resistance Level
  • ATRA $13.64
  • ALTS $4.00
  • Average True Range (ATR)
  • ATRA 0.96
  • ALTS 0.35
  • MACD
  • ATRA -0.27
  • ALTS 0.05
  • Stochastic Oscillator
  • ATRA 50.33
  • ALTS 90.12

About ATRA Atara Biotherapeutics Inc.

Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).

About ALTS ALT5 SIGMA CORPORATION

ALT5 Sigma Corp is a fintech company. It is providing next generation blockchain-powered technologies for tokenization, trading, clearing, settlement, payment and safe-keeping of digital assets. The company product include ALT 5 Prime is an electronic over-the-counter trading platform and ALT 5 Pay crypto payment processor.

Share on Social Networks: